A detailed history of Verition Fund Management LLC transactions in Bio Xcel Therapeutics, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 25,155 shares of BTAI stock, worth $17,860. This represents 0.0% of its overall portfolio holdings.

Number of Shares
25,155
Holding current value
$17,860
% of portfolio
0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$1.14 - $2.97 $28,676 - $74,710
25,155 New
25,155 $32,000
Q1 2023

May 15, 2023

BUY
$17.7 - $33.24 $235,728 - $442,690
13,318 New
13,318 $248,000
Q1 2020

May 15, 2020

SELL
$12.26 - $41.14 $208,370 - $699,215
-16,996 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$4.05 - $14.61 $68,833 - $248,311
16,996 New
16,996 $248,000

Others Institutions Holding BTAI

About BioXcel Therapeutics, Inc.


  • Ticker BTAI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,022,500
  • Market Cap $19.9M
  • Description
  • BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...
More about BTAI
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.